Financing
Debt Issuance Proceeds
Medtronic Debt Issuance Proceeds decreased by 100.0% to $0.00 in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $3.21B to $0.00. Over 3 years (FY 2021 to FY 2024), Debt Issuance Proceeds shows a downward trend with a -100.0% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ1 2026Aug 26, 2025
How to read this metric
An increase indicates successful access to capital markets for expansion or refinancing, while a decrease may suggest a focus on deleveraging or limited market access.
Detailed definition
This metric tracks the total cash proceeds received from the issuance of long-term or short-term debt instruments. It re...
Peer comparison
Large-cap companies frequently issue debt to optimize their cost of capital; peers monitor this to maintain investment-grade credit ratings.
Metric ID:
debt_issuanceHistorical Data
16 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $3.43B | -$3.43B | $0.00 | $2.28B | -$2.28B | $3.43B | $1.98B | $0.00 | $3.21B | -$3.21B | $0.00 | $3.21B | $1.46B | $0.00 |
| QoQ Change | — | — | — | -200.0% | +100.0% | — | -200.0% | +250.2% | -42.3% | -100.0% | — | -200.0% | +100.0% | — | -54.4% | -100.0% |
| YoY Change | — | — | — | — | — | — | -166.6% | +200.0% | — | -100.0% | +240.5% | -193.6% | -100.0% | — | +145.6% | -100.0% |
Range-$3.43B – $3.43B
Avg YoY Growth-9.3%
Median YoY Growth-100.0%
Current Streak2+ quarters decline
Debt Issuance Proceeds at Other Companies
Frequently Asked Questions
- What is Medtronic's debt issuance proceeds?
- Medtronic (MDT) reported debt issuance proceeds of $0.00 in Q2 2025.
- How has Medtronic's debt issuance proceeds changed year-over-year?
- Medtronic's debt issuance proceeds decreased by 100.0% year-over-year, from $3.21B to $0.00.
- What is the long-term trend for Medtronic's debt issuance proceeds?
- Over 3 years (2021 to 2024), Medtronic's debt issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $7.17B to $0.00.
- What does debt issuance proceeds mean?
- Cash received from taking on new debt.